Regulatory Insights

31. Are Your Trial Payments Creating Hidden Compliance Risks? 7/13/2026

    Clear separation of reimbursements, stipends, and site payments helps reduce compliance risk, improve transparency, and support ethical compensation.

32. Transforming Ophthalmic Assessments For A Mid-Trial Protocol Change 7/9/2026

    Discover how a biopharmaceutical company integrated urgent mid-trial mandates across 65 sites, cutting standard onboarding timelines in half while preserving critical enrollment milestones.

33. Who Is Responsible When AI Helps Write The Consent Form? 6/29/2026

    AI is reshaping consent materials, but accuracy, oversight, and transparency remain essential. As guidance evolves, organizations must balance innovation with accountability to protect participants.

34. The Power of AI To Advance Digital Health Innovation 6/18/2026

    Discover how leaders from Pfizer, Mayo Clinic, and the FDA use AI to advance digital endpoints in this 4-video recap of ADDS 2026. Learn to turn AI insights into scalable, regulatory-ready solutions.

35. DECODE CRS: Accelerating Immunotherapy Access And De-risking CRS 6/18/2026

    How does the DECODE CRS Coalition help trial sponsors standardize protocols and build a first-of-its-kind wearable dataset to lower development costs and safely de-risk outpatient care?

36. Navigating The New Landscape Of Oncology Clinical Trials: A Strategic Imperative For Operations Teams 6/18/2026

    The oncology landscape is growing but faces high screen-fail rates and trial complexity. To succeed, teams must move past traditional playbooks and adopt centralized pre-screening pipelines.

37. Strong Regulatory Foundations For Early-Phase Drug Development 6/17/2026

    Discover how an integrated regulatory strategy can help streamline development and accelerate your path to the clinic.

38. Regulatory Pathways By Region: A Guide For Early-Phase Trials 6/17/2026

    Explore key regulatory considerations across major global markets to support more efficient early-phase clinical development planning.

39. Financial Compliance In Clinical Trials Explained Clearly 6/16/2026

    An operational look at financial compliance in clinical trials, explaining how audit trails, traceability, and reporting function under real-world conditions, and why scale makes weak assumptions visible.

40. Can Your Trial Payment Approach Stand Up To Regulatory Scrutiny? 6/15/2026

    Fragmented trial payment systems create compliance, ethical, and operational risks. Aligning payments with regulations and ethics improves transparency, reduces burden, and supports audits and participation.